Allogene Therapeutics, Inc. ($ALLO)
Filing Information
| Accession Number | 0001362155-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
714,452
Total Value
$40,304.00
P&L
+inf% (+$1,431,512.64)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, General Counsel | Common Stock | โ | Feb 2, 2026 | Sale | 22,900 | $1.76 | $40,304.00 | 564,948 | Direct | โ | View Details | |
SVP, General Counsel | Stock Option (Right to buy) | Derivative | Feb 2, 2026 | Grant/Award | 539,072 | $0.00 | $0.00 | 539,072 | Direct | โ | View Details | |
SVP, General Counsel | Restricted Stock Unit | Derivative | Feb 2, 2026 | Grant/Award | 152,480 | $0.00 | $0.00 | 152,480 | Direct | โ | View Details |